Taking biopharmaceutical Visterra from investment to multi-million dollar M&A

26 July 2018

On July 11, news broke of an acquisition agreement between pharmaceutical companies Visterra Inc, a Vertex Ventures HC investment, and Otsuka Pharmaceutical Co Ltd. The deal will have Japan’s Otsuka acquire Massachusetts-based Visterra for around $430M in cash by Q3 2018. We first invested in Visterra in 2014, when they visited Singapore for a Series […]

Continue Reading